For pharmaceutical and biotechnology companies, the ability to successfully launch is of paramount importance to generate additional revenue and refinance R&D costs. However, the successful launch of new products does not mean these will sell themselves and thus a corresponding launch strategy with professional project and crisis management remains necessary. Without detailed planning of the product launch, the risk of failure is high.
We will support you with established techniques to ensure that your products’ market launches are a complete success. To achieve this, we use a comprehensive gap assessment by the means of a risk evaluation (traffic light technique), a comprehensive marketing plan with worst case and best case scenarios and an eight-step launch readiness framework as a central building block, which avoids risks due to incomplete planning and significantly accelerates the launch process.